EGFR and cancer: Further, EGa1 nanobody was coupled to the surface of the (mPEG/PDP-PEG)-b-p(HPMAm-Lacn) nanomicelles in order to enhance the specificity of the nanoscale carriers to EGFR-positive cancer cells and to improve recognition and intracellular uptake.